The Herald ghanaThe Herald ghana
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Reading: Cervical cancer vaccines save over 1 million lives in lower-income countries
Share
Aa
The Herald ghanaThe Herald ghana
Aa
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Search
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Follow US
  • Advertise
Copyright © 2022 The Herald Ghana. All Rights Reserved
HealthMajor 2

Cervical cancer vaccines save over 1 million lives in lower-income countries

Published November 18, 2025 6 Min Read
Share
6 Min Read
SHARE

More than 1 million cervical cancer deaths have been prevented, and an estimated 86 million girls are now protected against the leading cause of cervical cancer, thanks to a concerted three-year effort by Gavi, the Vaccine Alliance and lower-income countries.

This milestone, announced on the first World Cervical Cancer Elimination Day, follows a major revitalisation of Gavi’s HPV vaccine programme that began in 2023.

“Every two minutes, a woman dies from cervical cancer – a disease that is both devastating and largely preventable,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “In 2023, Gavi, in partnership with countries across the world, launched an ambitious campaign to protect 86 million girls against the primary cause of cervical cancer and prevent more than a million deaths.

Thanks to incredible commitment from countries, partners, civil society and communities, we have now reached that target ahead of schedule. This collaborative effort is driving major global progress towards eliminating one of the deadliest diseases affecting women.”

Cervical cancer strikes hardest in lower-income countries, which often lack screening services and equitable access to treatment. As a result, these countries account for 90% of the 350,000 deaths from cervical cancer recorded in 2022.

More Read

WHO warns 50m lives saved by vaccines at risk as US aid cuts, conflicts threaten Africa’s gains

Ghana launches HPV vaccine to protect over 2 million girls and combat cervical cancer
WHO supports Ghana’s response to Mpox outbreak with supplies and vaccines
GMA calls for urgent contact tracing of Covid-19 victims as cases soar

Yet a safe and effective vaccine exists. The HPV vaccine – which protects against the human papillomavirus, the primary cause of cervical cancer – is highly effective, averting 17.4 deaths for every 1,000 children vaccinated.

When Gavi launched its HPV vaccine programme in 2014, access to the vaccine remained limited and inequitable due to inadequate vaccine supply, lack of data on effective delivery methods, and lack of awareness of the importance of HPV vaccination.

 In Africa – home to many Gavi-supported countries and among the regions hardest hit by cervical cancer – coverage stood at 4%. Over the next eight years, Gavi worked with countries, partners and manufacturers to overcome challenges.

By the end of 2022, Gavi-supported HPV vaccinations had protected more than 13 million girls, yet coverage was still far from optimal – global coverage stood at just 14% of eligible girls, and in Africa, at 15%. 

In 2023, Gavi announced its intention to revitalise its HPV vaccine programme – with an ambitious target to protect 86 million girls by the end of 2025.

 Thanks to a three-year effort supported and coordinated by Gavi – and led and enabled by unprecedented commitment from national governments, civil society and partners across Gavi-eligible countries – this target has now been reached ahead of schedule.

These efforts are estimated to have prevented 1.4 million cervical cancer deaths and, with more than 50 countries introducing the vaccine with Gavi support by the end of 2025, the vaccine will be available in countries that collectively account for 89% of all cervical cancer cases globally.

 By the end of 2024, coverage in Africa had risen to 44% – surpassing coverage rates in Europe (38% by end 2024). HPV vaccine coverage across all Gavi-supported countries also steadily increased to 25% by end 2024, compared to 8% in 2022.

This investment in HPV vaccines is not only saving lives: it also generates measurable economic returns and helps to build stronger, more resilient communities.

 The prevention of illness and death from cervical cancer between 2014 and 2024 across all Gavi-supported countries will generate more than US$ 2.3 billion in economic benefits.

OVERCOMING BARRIERS TO SAVE LIVES

This ambitious push was enabled by the Alliance’s relentless focus on affordable access and overcoming barriers. By applying its market shaping expertise to lower the cost of vaccines while driving up supply by offering manufacturers guaranteed volumes, Gavi secured commitments from manufacturers to invest in HPV vaccines – and the price of HPV vaccines in Gavi-supported countries is now between US$ 2.90 and US$ 5.18 per dose, compared with US$ 100 or more elsewhere. Gavi and partners also spent years working with countries to prioritise vaccination against cervical cancer and to plan for large-scale immunisation activities once sufficient supply was available.

Partners also invested in data on how to effectively reach adolescent girls and critical vaccine efficacy studies. In 2022, the World Health Organization was able to officially recommend a single-dose HPV vaccine schedule (compared to two doses previously), enabling countries to reach twice as many girls with existing supply.

Next steps

Building on the momentum of this large global effort, Gavi’s support will enable up to seven more countries to integrate the HPV vaccine into their national immunisation programmes in the coming months.

This week, large-scale campaigns in Sierra Leone and Liberia are expanding protection to girls up to 18 years old, reaching those who previously missed out and advancing the global effort to ensure equitable access to vaccines and eliminate cervical cancer as a public health threat.

You Might Also Like

WHO warns 50m lives saved by vaccines at risk as US aid cuts, conflicts threaten Africa’s gains

Ghana launches HPV vaccine to protect over 2 million girls and combat cervical cancer

WHO supports Ghana’s response to Mpox outbreak with supplies and vaccines

GMA calls for urgent contact tracing of Covid-19 victims as cases soar

razak.bawa November 18, 2025
Share this Article
Facebook Twitter Whatsapp Whatsapp Copy Link
What do you think?
Love0
Sad0
Cry0
Happy0
Surprise0
Angry0
Wink0
Previous Article El-Wak stampede: 3 victims stabilise, 16 still on admission
Next Article 7,500 African SMEs to receive AI and digital trade skills through new google and AfCFTA secretariat programme

Stay Connected

Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe
- Advertisement -
Ad imageAd image

Latest News

court hammer/coup/marriage
Court of Appeal upholds life sentence for Jirapa Dubai hotel murder convict
General Major 4 November 19, 2026
Tottenham man arrested in Dublin over fatal stabbing of 21-year-old in North London
General Major 2 November 19, 2026
Emirates tops Time’s inaugural World’s Best Airlines 2027 rankings
Business Major 2 November 19, 2026
South Africa: Alex Dadey champions intergenerational African businesses, technology and regional partnerships at CNBC Africa Forum
Business Major 1 November 19, 2026
CurrencyRate

You Might also Like

HealthMajor 3

WHO warns 50m lives saved by vaccines at risk as US aid cuts, conflicts threaten Africa’s gains

April 16, 2026
HealthMajor 4

Ghana launches HPV vaccine to protect over 2 million girls and combat cervical cancer

October 9, 2025
HealthMajor 4

WHO supports Ghana’s response to Mpox outbreak with supplies and vaccines

August 6, 2025

GMA calls for urgent contact tracing of Covid-19 victims as cases soar

December 23, 2021

Copyright © 2022-2025 The Herald Ghana. All Rights Reserved

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?